Sign Out
Hypertension: to reduce blood pressure and to reduce the risk of cardiovascular and coronary mortality (including sudden death), and morbidity.
Angina pectoris.
Disturbances of cardiac rhythm including especially supraventricular tachycardia.
Maintenance treatment after myocardial infarction.
Functional heart disorders with palpitations.
Migraine prophylaxis.
23.75 mg: Symptomatic mild to severe chronic heart failure as an adjunct to other heart failure therapy: to increase survival, reduce hospitalisation, improve left ventricular function, improve New York Heart Association (NYHA) functional class and improve Quality of Life.
